Microcirculation lesions alone are not reliable for identifying antibody-mediated rejection

American Journal of Transplantation

Volumn 13, Issue 7, 2013, Pages 1931-1932

  Halloran, P F ^a,b   Sellares, J ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ANTIBODY MEDIATED REJECTION; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; DIAGNOSTIC TEST; GRAFT FAILURE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY TRANSPLANTATION; LETTER; MICROCIRCULATION; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE;

FEMALE; GRAFT REJECTION; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE;

EID: 84879553302     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12317     Document Type: Letter

References (4)

1. Naesens M, Kuypers DR, De VK, et al. Chronic histological damage in early indication biopsies is an independent risk factor for late renal allograft failure. Am J Transplant 2013; 13: 86-99.
2. Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS., The significance of the anti-class i antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplant 1990; 49: 85-91.
3. El Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9: 527-535.
4. Sellares J, De Freitas D, Mengel M, et al. Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and non-adherence. Am J Transplant 2012; 12: 388-399.